India News | Written by Uma Sudhir | Thursday September 24, 2020
Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...
www.ndtv.com